Entero Healthcare Solutions Limited (BOM:544122)
India · Delayed Price · Currency is INR 1,154.55
-1.45 (-0.13%)
At close: Feb 13, 2026
BOM:544122 Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Revenue | 60,034 | 50,958 | 39,223 | 33,002 | 25,221 | 17,731 |
Revenue Growth (YoY) | 25.31% | 29.92% | 18.85% | 30.85% | 42.24% | 31.38% |
Cost of Revenue | 54,215 | 46,144 | 35,744 | 30,348 | 23,143 | 16,398 |
Gross Profit | 5,818 | 4,814 | 3,480 | 2,654 | 2,077 | 1,333 |
Selling, General & Admin | 2,431 | 2,094 | 1,563 | 1,364 | 1,234 | 786.76 |
Other Operating Expenses | 1,259 | 994.87 | 798.01 | 650.33 | 599.12 | 346.13 |
Operating Expenses | 4,071 | 3,407 | 2,611 | 2,257 | 2,030 | 1,296 |
Operating Income | 1,747 | 1,407 | 868.26 | 397.7 | 46.84 | 37.22 |
Interest Expense | -434.74 | -375.35 | -604.82 | -444 | -260.95 | -163.8 |
Interest & Investment Income | 375.73 | 375.73 | 133.32 | 40.9 | 34.39 | 29.43 |
Currency Exchange Gain (Loss) | - | - | 0.34 | 0.15 | 1.58 | 3.83 |
Other Non Operating Income (Expenses) | -36.4 | -36.4 | -41.91 | -31.63 | -19.97 | -15.06 |
EBT Excluding Unusual Items | 1,652 | 1,371 | 355.19 | -36.88 | -198.11 | -108.38 |
Gain (Loss) on Sale of Investments | 9.6 | 9.6 | - | - | - | - |
Gain (Loss) on Sale of Assets | 1.92 | 1.92 | 0.36 | - | - | - |
Other Unusual Items | -76.91 | 4.87 | - | - | - | - |
Pretax Income | 1,586 | 1,387 | 355.55 | -36.88 | -198.11 | -108.38 |
Income Tax Expense | 264.79 | 313.05 | -42.44 | 74.16 | 96.28 | 45.16 |
Earnings From Continuing Operations | 1,321 | 1,074 | 397.99 | -111.04 | -294.39 | -153.54 |
Minority Interest in Earnings | -194.15 | -126.14 | -6.9 | -4.53 | -4.81 | -1.83 |
Net Income | 1,127 | 948.2 | 391.09 | -115.57 | -299.2 | -155.37 |
Net Income to Common | 1,127 | 948.2 | 391.09 | -115.57 | -299.2 | -155.37 |
Net Income Growth | 25.11% | 142.45% | - | - | - | - |
Shares Outstanding (Basic) | 44 | 43 | 36 | 4 | 2 | 0 |
Shares Outstanding (Diluted) | 44 | 44 | 36 | 4 | 2 | 0 |
Shares Change (YoY) | 2.37% | 20.45% | 779.74% | 163.71% | 1455.99% | - |
EPS (Basic) | 25.90 | 21.80 | 10.81 | -28.11 | -191.91 | -1550.60 |
EPS (Diluted) | 25.86 | 21.76 | 10.81 | -28.11 | -191.91 | -1550.60 |
EPS Growth | 22.21% | 101.30% | - | - | - | - |
Free Cash Flow | - | -881.8 | -420.28 | -508.34 | -451.31 | -782.13 |
Free Cash Flow Per Share | - | -20.24 | -11.62 | -123.64 | -289.47 | -7805.69 |
Gross Margin | 9.69% | 9.45% | 8.87% | 8.04% | 8.24% | 7.52% |
Operating Margin | 2.91% | 2.76% | 2.21% | 1.21% | 0.19% | 0.21% |
Profit Margin | 1.88% | 1.86% | 1.00% | -0.35% | -1.19% | -0.88% |
Free Cash Flow Margin | - | -1.73% | -1.07% | -1.54% | -1.79% | -4.41% |
EBITDA | 1,854 | 1,503 | 950.02 | 487.22 | 118.84 | 97.75 |
EBITDA Margin | 3.09% | 2.95% | 2.42% | 1.48% | 0.47% | 0.55% |
D&A For EBITDA | 106.91 | 96.13 | 81.76 | 89.52 | 72 | 60.53 |
EBIT | 1,747 | 1,407 | 868.26 | 397.7 | 46.84 | 37.22 |
EBIT Margin | 2.91% | 2.76% | 2.21% | 1.21% | 0.19% | 0.21% |
Effective Tax Rate | 16.69% | 22.56% | - | - | - | - |
Revenue as Reported | 60,429 | 51,353 | 39,367 | 33,057 | 25,265 | 17,837 |
Advertising Expenses | - | 90.42 | 44.88 | 65.88 | 70.98 | 17.73 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.